WHY CLIENTS CHOOSE US
Our senior management and laboratory staff are highly experienced scientific experts with decades of specialised expertise in regulated bioanalysis. Our bioanalytical expertise covers multiple species and biological matrices.
Why our clients choose us
At Agilex Biolabs, we deliver quality every time, for every project. Our clients choose us because we are the recognised leaders in bioanalytical excellence with 20 years of experience.
We are strategically co-located in the Tech Hub, in Adelaide, South Australia, which fosters innovation, collaboration, knowledge transfer and support for technology companies. Our world-class FDA inspected bioanalytical facilities have OECD GLP recognition with NATA (Australian Government OECD GLP compliance monitoring authority) and ISO 17025 Accreditation.
Like you, we are passionate about accelerating your drug to market. When you partner with us, you can be confident that your project will be delivered by the experts and with the highest quality results.
We offer 1000 m of world-class FDA inspected bioanalytical facilities with OECD GLP and ISO 17025 Accreditation. Our instrumentation delivers high-performance quantitation and identification, including six Sciex API 4000 LC-MS/MS systems, a Sciex QTRAP 5500 LC/MS-MS system, a Meso Scale Discovery (MSD) Quickplex SQ120 and Gyrolab xPlore units.
The robust and efficient Australian regulatory framework expedites the clinical trial process to benefit drug development.
The Australian regulatory framework CTN (Clinical Trial Notification) scheme for undertaking early phase clinical trials is the fastest in the world.
There is no requirement for Investigational New Drug (IND) for clinical trials. Additionally, some exemptions may apply to the requirement for full GMP compliance for initial experimental studies in First in Human trials. For further details please contact us.
The Australian Government’s Research and Development Tax Incentive offers up to 43.5% of cash back for research and development conducted Australia.
Let us refer you to an expert in Clinical Trial R&D tax legislation.
Please fill in this form and we will be in contact shortly: